AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

JPMorgan American Investment Trust PLC

Declaration of Voting Results & Voting Rights Announcements Dec 1, 2025

5167_dva_2025-12-01_d75540e4-cddf-411d-9c6f-1e616bbe1211.html

Declaration of Voting Results & Voting Rights Announcements

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 6684J

JPMorgan American IT PLC

01 December 2025

LONDON STOCK EXCHANGE ANNOUNCEMENT

TOTAL VOTING RIGHTS AND CAPITAL

JPMORGAN AMERICAN INVESTMENT TRUST PLC

(the 'Company')

Legal Entity Identifier: 549300QNAI4XRPEB4G65

Information disclosed in accordance with DTR 5.6.1R

In conformity with Rule 5.6.1 of the Financial Conduct Authority's (FCA's) Disclosure Guidance and Transparency Directive, the Company would like to notify the market of the following:

As at 30th November 2025 the Company's issued share capital consists of 281,633,910 Ordinary 5 pence shares with voting rights. The Company holds 110,894,654 Ordinary shares in Treasury.

Therefore, as at 30th November 2025, the total number of voting rights in JPMorgan American Investment Trust plc is 170,739,256.

The above figure (170,739,256) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, JPMorgan American Investment Trust plc under the FCA's Disclosure Guidance and Transparency Rules.

1st December 2025

For further information, please contact:

Divya Amin

For and on behalf of

JPMorgan Funds Limited - Company Secretary

0800 20 40 20 (or +44 1268 44 44 70)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

TVREANAFESDSFEA

Talk to a Data Expert

Have a question? We'll get back to you promptly.